世界の脊髄性筋萎縮症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Spinal Muscular Atrophy Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5404 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、脊髄性筋萎縮症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、髄腔内）、用途別市場規模（SMAタイプ1、SMAタイプ2、SMAタイプ3、SMAタイプ4）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・脊髄性筋萎縮症治療の市場動向 ・企業の競争状況、市場シェア ・脊髄性筋萎縮症治療の種類別市場規模（経口、髄腔内） ・脊髄性筋萎縮症治療の用途別市場規模（SMAタイプ1、SMAタイプ2、SMAタイプ3、SMAタイプ4） ・脊髄性筋萎縮症治療の北米市場規模2016-2027（アメリカ、カナダ） ・脊髄性筋萎縮症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・脊髄性筋萎縮症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・脊髄性筋萎縮症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・脊髄性筋萎縮症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Biogen、Roche、Avexis） ・結論

Spinal muscular atrophy is a genetic disorder characterized by weakness and wasting (atrophy ) in muscles used for movement (skeletal muscles). It is caused by a loss of specialized nerve cells, called motor neurons that control muscle movement. It’s not currently possible to cure spinal muscular atrophy (SMA), but research is ongoing to find new treatments.

Market Analysis and Insights: Global Spinal Muscular Atrophy Treatment Market
The global Spinal Muscular Atrophy Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Spinal Muscular Atrophy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Spinal Muscular Atrophy Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Spinal Muscular Atrophy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Spinal Muscular Atrophy Treatment market.

Global Spinal Muscular Atrophy Treatment Scope and Market Size
Spinal Muscular Atrophy Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Spinal Muscular Atrophy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Intrathecal

Segment by Application
SMA Type 1
SMA Type 2
SMA Type 3
SMA Type 4

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biogen

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal Muscular Atrophy Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Intrathecal
1.3 Market by Application
1.3.1 Global Spinal Muscular Atrophy Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 SMA Type 1
1.3.3 SMA Type 2
1.3.4 SMA Type 3
1.3.5 SMA Type 4
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Spinal Muscular Atrophy Treatment Market Perspective (2016-2027)
2.2 Spinal Muscular Atrophy Treatment Growth Trends by Regions
2.2.1 Spinal Muscular Atrophy Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Spinal Muscular Atrophy Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Spinal Muscular Atrophy Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Spinal Muscular Atrophy Treatment Industry Dynamic
2.3.1 Spinal Muscular Atrophy Treatment Market Trends
2.3.2 Spinal Muscular Atrophy Treatment Market Drivers
2.3.3 Spinal Muscular Atrophy Treatment Market Challenges
2.3.4 Spinal Muscular Atrophy Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Spinal Muscular Atrophy Treatment Players by Revenue
3.1.1 Global Top Spinal Muscular Atrophy Treatment Players by Revenue (2016-2021)
3.1.2 Global Spinal Muscular Atrophy Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Spinal Muscular Atrophy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Spinal Muscular Atrophy Treatment Revenue
3.4 Global Spinal Muscular Atrophy Treatment Market Concentration Ratio
3.4.1 Global Spinal Muscular Atrophy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy Treatment Revenue in 2020
3.5 Spinal Muscular Atrophy Treatment Key Players Head office and Area Served
3.6 Key Players Spinal Muscular Atrophy Treatment Product Solution and Service
3.7 Date of Enter into Spinal Muscular Atrophy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Spinal Muscular Atrophy Treatment Breakdown Data by Type
4.1 Global Spinal Muscular Atrophy Treatment Historic Market Size by Type (2016-2021)
4.2 Global Spinal Muscular Atrophy Treatment Forecasted Market Size by Type (2022-2027)

5 Spinal Muscular Atrophy Treatment Breakdown Data by Application
5.1 Global Spinal Muscular Atrophy Treatment Historic Market Size by Application (2016-2021)
5.2 Global Spinal Muscular Atrophy Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Spinal Muscular Atrophy Treatment Market Size (2016-2027)
6.2 North America Spinal Muscular Atrophy Treatment Market Size by Type
6.2.1 North America Spinal Muscular Atrophy Treatment Market Size by Type (2016-2021)
6.2.2 North America Spinal Muscular Atrophy Treatment Market Size by Type (2022-2027)
6.2.3 North America Spinal Muscular Atrophy Treatment Market Size by Type (2016-2027)
6.3 North America Spinal Muscular Atrophy Treatment Market Size by Application
6.3.1 North America Spinal Muscular Atrophy Treatment Market Size by Application (2016-2021)
6.3.2 North America Spinal Muscular Atrophy Treatment Market Size by Application (2022-2027)
6.3.3 North America Spinal Muscular Atrophy Treatment Market Size by Application (2016-2027)
6.4 North America Spinal Muscular Atrophy Treatment Market Size by Country
6.4.1 North America Spinal Muscular Atrophy Treatment Market Size by Country (2016-2021)
6.4.2 North America Spinal Muscular Atrophy Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Spinal Muscular Atrophy Treatment Market Size (2016-2027)
7.2 Europe Spinal Muscular Atrophy Treatment Market Size by Type
7.2.1 Europe Spinal Muscular Atrophy Treatment Market Size by Type (2016-2021)
7.2.2 Europe Spinal Muscular Atrophy Treatment Market Size by Type (2022-2027)
7.2.3 Europe Spinal Muscular Atrophy Treatment Market Size by Type (2016-2027)
7.3 Europe Spinal Muscular Atrophy Treatment Market Size by Application
7.3.1 Europe Spinal Muscular Atrophy Treatment Market Size by Application (2016-2021)
7.3.2 Europe Spinal Muscular Atrophy Treatment Market Size by Application (2022-2027)
7.3.3 Europe Spinal Muscular Atrophy Treatment Market Size by Application (2016-2027)
7.4 Europe Spinal Muscular Atrophy Treatment Market Size by Country
7.4.1 Europe Spinal Muscular Atrophy Treatment Market Size by Country (2016-2021)
7.4.2 Europe Spinal Muscular Atrophy Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size (2016-2027)
8.2 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Type
8.2.1 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Application
8.3.1 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Region
8.4.1 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Spinal Muscular Atrophy Treatment Market Size (2016-2027)
9.2 Latin America Spinal Muscular Atrophy Treatment Market Size by Type
9.2.1 Latin America Spinal Muscular Atrophy Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Spinal Muscular Atrophy Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Spinal Muscular Atrophy Treatment Market Size by Type (2016-2027)
9.3 Latin America Spinal Muscular Atrophy Treatment Market Size by Application
9.3.1 Latin America Spinal Muscular Atrophy Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Spinal Muscular Atrophy Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Spinal Muscular Atrophy Treatment Market Size by Application (2016-2027)
9.4 Latin America Spinal Muscular Atrophy Treatment Market Size by Country
9.4.1 Latin America Spinal Muscular Atrophy Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Spinal Muscular Atrophy Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size (2016-2027)
10.2 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Type
10.2.1 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Application
10.3.1 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Country
10.4.1 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Spinal Muscular Atrophy Treatment Introduction
11.1.4 Biogen Revenue in Spinal Muscular Atrophy Treatment Business (2016-2021)
11.1.5 Biogen Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Spinal Muscular Atrophy Treatment Introduction
11.2.4 Roche Revenue in Spinal Muscular Atrophy Treatment Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Avexis
11.3.1 Avexis Company Details
11.3.2 Avexis Business Overview
11.3.3 Avexis Spinal Muscular Atrophy Treatment Introduction
11.3.4 Avexis Revenue in Spinal Muscular Atrophy Treatment Business (2016-2021)
11.3.5 Avexis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Spinal Muscular Atrophy Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Intrathecal
Table 4. Global Spinal Muscular Atrophy Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Spinal Muscular Atrophy Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Spinal Muscular Atrophy Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Spinal Muscular Atrophy Treatment Market Share by Regions (2016-2021)
Table 8. Global Spinal Muscular Atrophy Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Spinal Muscular Atrophy Treatment Market Share by Regions (2022-2027)
Table 10. Spinal Muscular Atrophy Treatment Market Trends
Table 11. Spinal Muscular Atrophy Treatment Market Drivers
Table 12. Spinal Muscular Atrophy Treatment Market Challenges
Table 13. Spinal Muscular Atrophy Treatment Market Restraints
Table 14. Global Spinal Muscular Atrophy Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Spinal Muscular Atrophy Treatment Market Share by Players (2016-2021)
Table 16. Global Top Spinal Muscular Atrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Muscular Atrophy Treatment as of 2020)
Table 17. Ranking of Global Top Spinal Muscular Atrophy Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Spinal Muscular Atrophy Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Spinal Muscular Atrophy Treatment Product Solution and Service
Table 21. Date of Enter into Spinal Muscular Atrophy Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Spinal Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Spinal Muscular Atrophy Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Spinal Muscular Atrophy Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Spinal Muscular Atrophy Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Spinal Muscular Atrophy Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Spinal Muscular Atrophy Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Spinal Muscular Atrophy Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Spinal Muscular Atrophy Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Spinal Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Spinal Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Spinal Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Spinal Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Spinal Muscular Atrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Spinal Muscular Atrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Spinal Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Spinal Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Spinal Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Spinal Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Spinal Muscular Atrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Spinal Muscular Atrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Spinal Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Spinal Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Spinal Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Spinal Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Spinal Muscular Atrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Spinal Muscular Atrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Biogen Company Details
Table 62. Biogen Business Overview
Table 63. Biogen Spinal Muscular Atrophy Treatment Product
Table 64. Biogen Revenue in Spinal Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
Table 65. Biogen Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Spinal Muscular Atrophy Treatment Product
Table 69. Roche Revenue in Spinal Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Avexis Company Details
Table 72. Avexis Business Overview
Table 73. Avexis Spinal Muscular Atrophy Treatment Product
Table 74. Avexis Revenue in Spinal Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
Table 75. Avexis Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Spinal Muscular Atrophy Treatment Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Intrathecal Features
Figure 4. Global Spinal Muscular Atrophy Treatment Market Share by Application: 2020 VS 2027
Figure 5. SMA Type 1 Case Studies
Figure 6. SMA Type 2 Case Studies
Figure 7. SMA Type 3 Case Studies
Figure 8. SMA Type 4 Case Studies
Figure 9. Spinal Muscular Atrophy Treatment Report Years Considered
Figure 10. Global Spinal Muscular Atrophy Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Spinal Muscular Atrophy Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Spinal Muscular Atrophy Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Spinal Muscular Atrophy Treatment Market Share by Regions (2022-2027)
Figure 14. Global Spinal Muscular Atrophy Treatment Market Share by Players in 2020
Figure 15. Global Top Spinal Muscular Atrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Muscular Atrophy Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy Treatment Revenue in 2020
Figure 17. Global Spinal Muscular Atrophy Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Spinal Muscular Atrophy Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Spinal Muscular Atrophy Treatment Market Share by Type (2016-2027)
Figure 21. North America Spinal Muscular Atrophy Treatment Market Share by Application (2016-2027)
Figure 22. North America Spinal Muscular Atrophy Treatment Market Share by Country (2016-2027)
Figure 23. United States Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Spinal Muscular Atrophy Treatment Market Share by Type (2016-2027)
Figure 27. Europe Spinal Muscular Atrophy Treatment Market Share by Application (2016-2027)
Figure 28. Europe Spinal Muscular Atrophy Treatment Market Share by Country (2016-2027)
Figure 29. Germany Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Spinal Muscular Atrophy Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Spinal Muscular Atrophy Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Spinal Muscular Atrophy Treatment Market Share by Region (2016-2027)
Figure 39. China Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Spinal Muscular Atrophy Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Spinal Muscular Atrophy Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Spinal Muscular Atrophy Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Spinal Muscular Atrophy Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Spinal Muscular Atrophy Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Spinal Muscular Atrophy Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Spinal Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Biogen Revenue Growth Rate in Spinal Muscular Atrophy Treatment Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Spinal Muscular Atrophy Treatment Business (2016-2021)
Figure 60. Avexis Revenue Growth Rate in Spinal Muscular Atrophy Treatment Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

---